Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 144
Filter
2.
Oncogene ; 34(35): 4647-55, 2015 Aug 27.
Article in English | MEDLINE | ID: mdl-25486434

ABSTRACT

Somatic mutations in the gene encoding the catalytic subunit of protein phosphatase 6 (Ppp6c) have been identified in malignant melanoma and are thought to function as a driver in B-raf- or N-ras-driven tumorigenesis. To assess the role of Ppp6c in carcinogenesis, we generated skin keratinocyte-specific Ppp6c conditional knockout mice and performed two-stage skin carcinogenesis analysis. Ppp6c deficiency induced papilloma formation with 7,12-dimethylbenz (a) anthracene (DMBA) only, and development of those papillomas was significantly accelerated compared with that seen following DMBA/TPA (12-O-tetradecanoylphorbol 13-acetate) treatment of wild-type mice. NF-κB activation either by tumor necrosis factor (TNF)-α or interleukin (IL)-1ß was enhanced in Ppp6c-deficient keratinocytes. Overall, we conclude that Ppp6c deficiency predisposes mice to skin carcinogenesis initiated by DMBA. This is the first report showing that such deficiency promotes tumor formation in mice.


Subject(s)
Phosphoprotein Phosphatases/genetics , Skin Neoplasms/enzymology , 9,10-Dimethyl-1,2-benzanthracene , Animals , Carcinogenesis/metabolism , Cells, Cultured , Keratinocytes/enzymology , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , NF-kappa B/metabolism , Phosphoprotein Phosphatases/metabolism , Signal Transduction , Skin/enzymology , Skin/pathology , Skin Neoplasms/chemically induced
3.
J Periodontal Res ; 45(4): 579-82, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20337884

ABSTRACT

BACKGROUND AND OBJECTIVE: The epithelium provides an important barrier against microbial invasion. Tight junction structural proteins called claudins are known to contribute to the epithelial cell barrier. Junctional epithelium is located at a strategically important interface between gingival sulcus and is interconnected by desmosomes and gap junctions, but not by tight junctions. Although claudins are tight junction-associated proteins, they are also expressed in the epithelium despite its lack of tight junctions in invertebrates. Therefore, claudins may play an important role in junctional epithelium without tight junctions. E-cadherin is a key molecule in the formation of adherence junctions and desmosomes. In the present study, we aimed to investigate the expressions of claudin-1,claudin-3, claudin-7 and E-cadherin in the junctional epithelium of Fischer 344 rats. MATERIAL AND METHODS: Gingival tissues from Fischer 344 rats were analyzed by immunohistochemical staining for claudin-1, claudin-3, claudin-7, and E-cadherin. RESULTS: Intense staining for claudin-1 and E-cadherin were observed in the junctional epithelium. In contrast to claudin-1, claudin-3 was mainly expressed in oral gingival epithelium and claudin-7 could not be detected on immunohistochemical analysis of the rat gingiva. CONCLUSION: These data suggest that claudin-1 and E-cadherin exist in the junctional epithelium and may play an important role in epithelial barrier function.


Subject(s)
Epithelial Attachment/cytology , Membrane Proteins/analysis , Tight Junctions/ultrastructure , Animals , Cadherins/analysis , Claudin-1 , Claudin-3 , Claudins , Coloring Agents , Epithelial Cells/cytology , Fluorescent Dyes , Gingiva/cytology , Immunohistochemistry , Male , Mouth Mucosa/cytology , Rats , Rats, Inbred F344
4.
J Periodontal Res ; 43(5): 508-13, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18565136

ABSTRACT

BACKGROUND AND OBJECTIVE: Irsogladine maleate (IM) suppresses the increase in interleukin (IL)-8 production induced by outer membrane protein (OMP) 29 from Aggregatibacter (Actinobacillus) actinomycetemcomitans in cultures of human gingival epithelial cells (HGEC). However, how IM suppresses the OMP29-induced increase in IL-8 expression remains unknown. In this study, we focused on intracellular signaling pathways to elucidate the mechanism behind the suppression. MATERIAL AND METHODS: HGEC, which had been pretreated with inhibitors of intracellular signaling molecules, were exposed to OMP29 (1 microg/mL) with or without IM (1 microM). IL-8 expression at the mRNA and protein levels was examined by real-time polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. Extracellular signal-regulated kinase (ERK) activity was measured with a p44/42 mitogen-activated protein kinase assay kit. RESULTS: An ERK inhibitor, PD98059, as well as IM, obviated the OMP29-induced increase in IL-8 levels in HGEC. A Jun kinase inhibitor, SP600125, and a nuclear factor kappaB inhibitor, PDTC, did not influence the OMP29-induced increase in IL-8 mRNA expression. The OMP29 stimulated phosphorylation of ERK in HGEC. Irsogladine maleate inhibited the phosphorylation. CONCLUSION: The suppression of the phosphorylation of ERK by IM in HGEC culminates in inhibition of the OMP29-induced increase in IL-8.


Subject(s)
Aggregatibacter actinomycetemcomitans/chemistry , Bacterial Outer Membrane Proteins/physiology , Epithelial Cells/enzymology , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Gingiva/enzymology , Interleukin-8/antagonists & inhibitors , MAP Kinase Signaling System/drug effects , Protein Kinase Inhibitors/pharmacology , Triazines/pharmacology , Cells, Cultured , Epithelial Cells/immunology , Extracellular Signal-Regulated MAP Kinases/physiology , Gingiva/cytology , Gingiva/immunology , Gingiva/microbiology , Humans , Interleukin-8/biosynthesis , Interleukin-8/blood , Phosphorylation/drug effects
5.
J Periodontal Res ; 43(1): 96-102, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18230110

ABSTRACT

BACKGROUND AND OBJECTIVE: Irsogladine maleate counters gap junctional intercellular communication reduction induced by interleukin-8 or Actinobacillus actinomycetemcomitans in cultured human gingival epithelial cells. Interleukin-1 beta is involved in periodontal disease. Little is known, however, about the effect of interleukin-1 beta on intercellular junctional complexes in human gingival epithelial cells. Furthermore, irsogladine maleate may affect the actions of interleukin-1 beta. In this study, we examined how interleukin-1 beta affected gap junctional intercellular communication, connexin 43 and zonula occludens protein-1, and how irsogladine maleate modulated the interleukin-1 beta-induced changes in the intercellular junctional complexes in human gingival epithelial cells. MATERIAL AND METHODS: Human gingival epithelial cells were exposed to interleukin-1 beta, with or without irsogladine maleate. Connexin 43 and zonula occludens protein-1 were examined at mRNA and protein levels by real-time polymerase chain reaction and western blotting, respectively. Gap junctional intercellular communication was determined using the dye transfer method. The expression of zonula occludens protein-1 was also confirmed by immunofluorescence. RESULTS: Interleukin-1 beta decreased connexin 43 mRNA levels, but increased zonula occludens protein-1 mRNA levels. Irsogladine maleate countered the interleukin-1 beta-induced reduction in gap junctional intercellular communication and connexin 43 levels. However, irsogladine maleate did not influence the increased zonula occludens protein-1 levels. CONCLUSION: The effect of interleukin-1 beta on gap junctional intercellular communication and tight junctions of human gingival epithelial cells is different. The recovery of gap junctional intercellular communication by irsogladine maleate in the gingival epithelium may be a normal process in gingival epithelial homeostasis.


Subject(s)
Antineoplastic Agents/pharmacology , Epithelial Cells/drug effects , Gap Junctions/drug effects , Interleukin-1beta/antagonists & inhibitors , Membrane Proteins/metabolism , Phosphoproteins/metabolism , Triazines/pharmacology , Connexin 43/metabolism , Epithelial Cells/cytology , Gap Junctions/metabolism , Gingiva/cytology , Humans , Interleukin-1beta/metabolism , Interleukin-1beta/pharmacology , RNA, Messenger/metabolism , Zonula Occludens-1 Protein
6.
Rinsho Ketsueki ; 42(9): 713-5, 2001 Sep.
Article in Japanese | MEDLINE | ID: mdl-11680985

ABSTRACT

A 56-year-old woman, who had been suffering from idiopathic cold agglutinin disease and treated unsuccessfully with prednisolone and cyclosporine A for 6 months, was referred to our hospital in November 1998. She was given methylprednisolone pulse therapy followed by low-dose cyclophosphamide, but her anemia did not improve. We then began administration of intermittent high-dose cyclophosphamide (1,200 mg/day, every 4 weeks), and this resulted in a dramatic increase of her hemoglobin level and improvement of her symptoms. She is currently receiving 500 mg of cyclophosphamide every 2 months and showing a good response. Intermittent high-dose cyclophosphamide therapy can be an effective treatment for refractory cold agglutinin disease.


Subject(s)
Anemia, Hemolytic, Autoimmune/drug therapy , Cyclophosphamide/administration & dosage , Immunosuppressive Agents/administration & dosage , Drug Administration Schedule , Female , Humans , Middle Aged , Treatment Outcome
7.
Biochem Biophys Res Commun ; 287(2): 562-7, 2001 Sep 21.
Article in English | MEDLINE | ID: mdl-11554766

ABSTRACT

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) is an activator of AMP activated protein kinase (AMPK) and a regulator of de novo purine synthesis. There are several earlier reports indicating that AICAR treatment suppresses cell growth via regulation of AMPK or de novo purine synthesis. We found cell growth to be suppressed by AICAR treatment in HepG2 because of p53 accumulation, which was associated with p53-Ser15 phosphorylation. Moreover, a motif very similar to the consensus motif of AMPK phosphorylation was found around p53-Ser15, and Ser15 phosphorylation was detected in AICAR treated HepG2 as was in vitro phosphorylation by AMPK. Our results suggest that AICAR may regulate cell growth via p53 phosphorylation, and also indicate the possibility of p53 phosphorylation.


Subject(s)
Aminoimidazole Carboxamide/analogs & derivatives , Aminoimidazole Carboxamide/pharmacology , Carcinoma, Hepatocellular/pathology , Multienzyme Complexes/metabolism , Protein Serine-Threonine Kinases/metabolism , Ribonucleotides/pharmacology , Tumor Suppressor Protein p53/metabolism , AMP-Activated Protein Kinases , Carcinoma, Hepatocellular/metabolism , Cell Division/drug effects , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/biosynthesis , Cyclins/drug effects , Enzyme Activation/drug effects , G1 Phase/drug effects , Humans , Hypoglycemic Agents/pharmacology , Phosphorylation/drug effects , S Phase/drug effects , Tumor Cells, Cultured , Tumor Suppressor Protein p53/physiology
8.
Environ Sci Technol ; 35(14): 2861-6, 2001 Jul 15.
Article in English | MEDLINE | ID: mdl-11478235

ABSTRACT

The main sources of dioxin emissions are municipal solid waste incinerators. The Japanese national government has set an emission standard for dioxins to reduce dioxin exposure levels. In this study, cost-effectiveness analyses are carried out regarding countermeasures that were recently taken and are being taken at municipal solid waste incinerators in Japan. Annual costs were estimated by telephone survey and model calculations. Annual decrease in the incidence of cancer was estimated in three steps. First, the annual decrease in the volume of dioxin emissions was estimated. Next, using a mathematical model, the annual decrease in human exposure was estimated. Finally, the annual decrease in the incidence of cancer was estimated by applying the cancer slope factor. When annual costs are divided by the annual number of life-years saved, cost per life-year saved (CPLYS) was obtained. CPLYS was estimated to be 7.9 million yen for emergency countermeasures and 150 million yen for long-term countermeasures. However, it must be noted that these obtained CPLYSs are highly dependent on the cancer slope factor and should be considered as an upper limit since there may be a cancer effect threshold.


Subject(s)
Air Pollution/prevention & control , Carcinogens/analysis , Dioxins/analysis , Refuse Disposal/methods , Carcinogens/adverse effects , Cost-Benefit Analysis , Dioxins/adverse effects , Environmental Exposure , Humans , Incidence , Incineration , Models, Theoretical , Neoplasms/epidemiology , Neoplasms/prevention & control
9.
J Biol Chem ; 276(38): 35227-30, 2001 Sep 21.
Article in English | MEDLINE | ID: mdl-11473105

ABSTRACT

Using the yeast prion as a model, we have developed a novel system to observe the growth of individual prion fibers directly. NM fragments, the prion-determining region of the yeast protein Sup35p, were labeled by either red or green fluorescent dyes, and the fiber growth was observed under a fluorescence microscope. When green-Sup35NM was added to the preformed fibers made of red-Sup35NM, 70-97% of green fibers grew unidirectionally, from only one end of individual red fibers, whereas the remainder grew from both ends. Similarly, the majority of red fibers grew from only one end of green fibers when the order of addition was reversed. Sonication of preformed fibers to expose fresh ends did not change the results, excluding a possibility of occasional deformation of one end as the reason of the apparent unidirectional growth. These results indicate the polarity of Sup35 prion fibers and impose constraints on the models of fiber growth.


Subject(s)
Prions/physiology , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/metabolism , Base Sequence , DNA Primers , Fungal Proteins/metabolism , Microscopy, Fluorescence , Peptide Termination Factors
10.
Leuk Lymphoma ; 40(5-6): 663-6, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11426538

ABSTRACT

Primary lymphomas of spermatic cord are extremely rare. In a review of the world medical literature, until now, only fourteen cases of spermatic cord lymphoma have been reported, and, furthermore, they have a poor prognosis even in patients with stage I disease. Herein, we report a new case of primary non-Hodgkin's lymphoma of the spermatic cord. In August, 1993, 76-year-old man visited an urological hospital with a compaint of a right intrascoral mass, and underwent orchiectomy. Macroscopically no invasive lesion in the testis was observed, and the tumorous lesion was restricted to the epididymis. The histopathological study indicated that he suffered from primary malignant lymphoma of the spermatic cord (B-cell, diffuse medium-sized cell type). As radiographic investigations showed no other invasive lesion, the patient was diagnosed to be in stage IE. He was followed only with clinical observation, and, in August, 1996, relapsed with extensive disease in the abdoninal cavity, and was transferred to our hospital. Fourty months after the orchiectomy, he died of progression of disease irrespective of the salvage radio-chemotherapies given to him.


Subject(s)
Genital Neoplasms, Male , Lymphoma, B-Cell , Spermatic Cord/pathology , Aged , Humans , Male
11.
Laryngoscope ; 111(2): 272-7, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11210874

ABSTRACT

OBJECTIVE/HYPOTHESIS: This study was undertaken to detect the faculty of secretion of saliva from minor salivary glands by analyzing a color reaction on a test tape containing iodine and starch that was applied on the lower lip. STUDY DESIGN: A study involving 63 patients with oral dryness, 7 patients with Sjogren syndrome, and 70 healthy individuals was performed. METHODS: A test tape (1 x 1 cm) containing iodine and starch was set on the mucosal area anterior to the labia frenulum for 30 seconds. Because the number of blue spots was considered to correspond to the number of ostia of the salivary gland on the lower lip that was examined, the number of blue spots occurring as a reaction of iodine and starch on the test tape was counted and was compared among three groups. In addition, the relationship between the histopathological findings and the number of spots was analyzed. RESULTS: The average number of spots in the patients with oral dryness (4.52+/-3.18 [mean +/- SD]) was lower than that in healthy individuals (9.49+/-2.52, P <.01), and that in the patients with Sjögren syndrome (2.14+/-1.35) was the lowest among all groups in the study. Moreover, this reduction in the number of spots in those patients was accompanied by histopathological changes of the minor salivary glands. CONCLUSION: These findings suggest that this simple, noninvasive method can be successfully used for the estimation of the faculty of secretion of saliva from the minor salivary glands.


Subject(s)
Iodine , Saliva/metabolism , Salivary Glands, Minor/physiopathology , Sjogren's Syndrome/diagnosis , Starch , Xerostomia/diagnosis , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Reference Values , Salivary Glands, Minor/pathology , Sjogren's Syndrome/pathology , Sjogren's Syndrome/physiopathology , Xerostomia/pathology , Xerostomia/physiopathology
12.
Rinsho Ketsueki ; 41(12): 1273-6, 2000 Dec.
Article in Japanese | MEDLINE | ID: mdl-11201153

ABSTRACT

A 68-year-old man, who had suffered a tick bite one week previously, consulted his home doctor because of fever and an erythematous rash around the bite scar. He underwent a skin biopsy, and Borrelia garinii was detected, from which Lyme disease was diagnosed. He received amoxicillin for two weeks and his symptoms disappeared. After 6 months he noticed swelling of his cervical, axillary and inguinal lymph nodes. A biopsy sample was taken from a left cervical lymph node, and this revealed angioimmunoblastic T-cell lymphoma. The patient achieved a complete remission after chemotherapy. The relationship between Lyme disease and lymphoma is discussed.


Subject(s)
Lyme Disease/complications , Lymphoma, T-Cell/etiology , Aged , Amoxicillin/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Humans , Lyme Disease/drug therapy , Lymphoma, T-Cell/drug therapy , Male , Penicillins/administration & dosage , Prednisone/administration & dosage , Time Factors , Vincristine/administration & dosage
14.
Cell Tissue Res ; 297(2): 329-35, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10470503

ABSTRACT

Plasma proteins termed "SP1" and "30K proteins" are synthesized by the fat body cells of the silkworm, Bombyx mori, in a sex- and stage-specific manner during larval development. We successfully established a primary culture of the fat body cells in order to investigate the regulatory mechanisms of plasma protein gene expression. The primary cultures of fat body cells contained at least two cell types: small oval cells, and large spherical cells. The cells adhered to and migrated on the cultured dish after plating. By the 7th day of cultivation, the cells clustered to form fat body-like structures, which were maintained for at least 3 months. Plasma proteins were actively synthesized in the primary cultures of the fat body cells isolated from the final instar larvae only when the cells tightly adhered to and clustered on the cultured dish. Immunocytochemical analysis revealed that only 10-15% of the clustered cells synthesized plasma proteins in our culture system, indicating that the primary culture comprises heterogeneous cells that are morphologically and functionally distinct. The patterns of SP1 syntheses in primary cultures faithfully reproduced their sex-dependency in vivo.


Subject(s)
Blood Proteins/biosynthesis , Bombyx/metabolism , Fat Body/metabolism , Insect Proteins/biosynthesis , Animals , Bombyx/cytology , Cells, Cultured , Fat Body/cytology , Female , Immunohistochemistry , Larva/growth & development , Larva/metabolism , Male , Sex Characteristics
16.
Psychiatry Clin Neurosci ; 52(1): 3-12, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9682927

ABSTRACT

A history of investigation on the antimanic and prophylactic effects of carbamazepine in Japan is described. Following the initial open trials in the early 1970s in which the antimanic and prophylactic effects of carbamazepine were indicated for the first time in the world, the mood stabilizing effect was confirmed by the double blind studies which were performed with a multi-institutional cooperation in Japan in the late 1970s. During the course of the double blind trials, the problem of different therapeutic dosages of psychotropic drugs between Japan and Western countries emerged; that is, the doses of chlorpromazine and lithium carbonate, which were used as the control drugs to carbamazepine in the two double-blind group-comparison studies in Japan, were both much lower than the dosage used in most of the Western countries. The low dosage of control drugs made the evaluation of the results of the double blind studies performed in Japan difficult, and caused a delay of publication in the Western journals of the results. Whether the difference is due to biological factors or to psychosocial and cultural factors is an important problem in psychopharmacology and should be investigated further.


Subject(s)
Anticonvulsants/history , Antimanic Agents/history , Carbamazepine/history , Anticonvulsants/therapeutic use , Antimanic Agents/therapeutic use , Carbamazepine/therapeutic use , History, 20th Century , Humans , Japan
17.
Biosci Biotechnol Biochem ; 62(3): 540-5, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9571784

ABSTRACT

An acidic-phospholipid deficiency caused by the pgsA3 allele that encodes a defective phosphatidylglycerophosphate synthase in Escherichia coli is lethal. The only known mutations that suppress this lethality fully have been related to the major outer-membrane lipoprotein. We isolated a Bacillus subtilis chromosomal locus that suppresses the lethality when harbored in a low copy-number plasmid, without restoring the synthase activity or phospholipid composition to normal. The locus was first recognized to suppress the conditional lethality of E. coli YA5512 (pgsA3) that harbored an unidentified mutation(s), allowing its growth in LB medium but not in media of lower osmolarities. The locus was then found to suppress the lethality of pgsA3 in wild-type E. coli W3110. This locus, named ypoP in the database, had 37% nucleotide identity with the E. coli mprA gene, but the amplification of mprA had no suppressive effect. Plasmid pPOP1 containing ypoP completely prevented the decrease in the amount of a porin protein, OmpF, in the outer membrane and also cell mucoidy caused by pgsA3. The mechanisms underlying these unusual effects are discussed in relation to a putative stress signal(s) generated by the acidic-phospholipid deficiency.


Subject(s)
Bacillus subtilis/genetics , Bacillus subtilis/metabolism , Chromosomes, Bacterial , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression Regulation, Bacterial , Genes, Lethal , Mutation , Phospholipids/deficiency , Alleles , DNA, Bacterial/genetics , DNA, Bacterial/metabolism , Genes, Bacterial , Genes, Suppressor , Hydrogen-Ion Concentration , Phospholipids/genetics
18.
Intern Med ; 35(9): 720-3, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8915699

ABSTRACT

A 57-year-old woman was admitted for evaluation of liver dysfunction. A physical examination revealed jaundice and a left abdominal mass, which was diagnosed as being a large renal tumor. Cholangiography showed a smooth filling defect 1 cm in diameter at the common bile duct. Left nephrectomy, and resection of the common bile duct were performed. The pathological diagnosis was metastasis of the common bile duct wall resulting from renal cell carcinoma. Metastatic common bile duct tumors are extremely rare. However, it is important to consider that this is one of the causes of obstructive jaundice.


Subject(s)
Carcinoma, Renal Cell/secondary , Common Bile Duct Neoplasms/secondary , Kidney Neoplasms/pathology , Carcinoma, Renal Cell/diagnostic imaging , Carcinoma, Renal Cell/pathology , Cholangiography , Cholestasis/etiology , Common Bile Duct Neoplasms/diagnostic imaging , Common Bile Duct Neoplasms/pathology , Female , Humans , Middle Aged , Tomography, X-Ray Computed
19.
Article in Japanese | MEDLINE | ID: mdl-8640461

ABSTRACT

Clinical trial with a steroid suppressive agent, metyrapone, was carried out in 6 patients with treatment-resistant depression (3 patients with major depression and 3 with bipolar disorder). Up to 2,000 mg/day of metyrapone was administered for 4 weeks, and 10 trials of the therapy were done in these patients. Most patients completed the therapy without remarkable side effects. As a result, three patients (6 trials) showed remission within 4 weeks and one patient (one trial) showed a partial response. In the remitted patients, plasma cortisol levels were suppressed below 10 micrograms/dl during the therapy and plasma ACTH levels were elevated. These results indicate that "hypercortisolemia-induced depression" similar to Cushing's disease may be present in patients with treatment-resistant depression.


Subject(s)
Depression/drug therapy , Hydrocortisone/biosynthesis , Metyrapone/therapeutic use , Adrenocortical Hyperfunction/complications , Adrenocortical Hyperfunction/drug therapy , Adrenocorticotropic Hormone/blood , Adult , Depression/etiology , Depression, Chemical , Female , Humans , Hydrocortisone/blood , Male , Metyrapone/pharmacology , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...